Transparency Market Research Report Added "Cattle Biologics Manufacturing Market" to its database.
Albany, NY -- (SBWIRE) -- 02/24/2016 -- Transparency Market Research's report, titled 'Cattle Biologics Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014–2020,' analyzes the market based on major segments, geographies, and current trends. The study predicts the global cattle biologics manufacturing market to report steady growth till 2020.
Cattle biologics are defined as the vaccines, bacterins, and diagnostics that aid the prevention, diagnosis, and treatment of diseases in cattle. Biologics, which work through immunological pathways, are capturing the attention of the animal husbandry sector because they hold the possibility of treating animals faster and more effectively than conventional therapies. This positive sentiment about biologics will help drive the global cattle biologics market globally.
The global cattle biologics manufacturing market can be segmented based on four major product segments: Vaccines, antibodies, pre-breeding vaccines for calves, and diagnostic kits. Of these, the vaccines segment and the pre-breeding vaccines for calves segment collectively hold a large share of the market. These vaccines help safeguard cattle against contracting diseases and infections such as bovine vibriosis, clostridial diseases, bovine virus diarrhea, and anthrax.
Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3608
Likewise, based on the manufacturing technique, the global cattle biologics market is segmented thus: Bacterins, non-bacterins, bacterin toxoid, and custom made vaccines. A bacterin refers to a suspension of killed bacteria meant for use as a vaccine to help cattle develop immunity against that bacteria. Bacterin toxoids, on the other hand, are live bacteria used for vaccination. Texas Vet Lab, Inc. boasts a wide portfolio of products, making it one of the leaders in the bacterin toxoid and bacterins space.
The report also discusses the trend of custom-made vaccines, which is gaining traction in the global cattle biologics manufacturing market. Custom-made vaccines are now increasingly favored over regular vaccines. This trend is especially evident in the U.S. cattle biologics manufacturing market. Newport Laboratories is a leading company that offers custom-made vaccines manufactured to immunize cattle against a specific bacteria or virus. Custom-made vaccines also facilitate veterinarians and vaccine manufacturers to devise flexible treatment plans by mixing different products.
Moving further, the report segments the global cattle biologics manufacturing market based on the type of vaccine provided to calves. The market can be segmented into: infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD), leptospirosis, trichomoniasis, and clostridium. BVD represents the largest segment among these.
From the geographical standpoint, the report identifies North America and Europe as the top regional markets for cattle biologics manufacturing. The large cattle population here and the economic ability of farmers to afford vaccination for their livestock to produce healthier products can be credited for the market being well-developed in these regions. Switzerland is a key European market for cattle biologics and manufacturing. In North America, regulatory agencies such as the Canadian Food Inspection Agency (CFIA) are helping boost the demand for cattle biologics through their stringent policies.
Companies that hold an appreciable stake in the global market for cattle biologics manufacturing are: Addison Cattle Corporation, Biocor Animal Health, Inc., Agrilabs, Colorado Serum Company, Boehringer Ingelheim, Fort Dodge Animal Health, Durvet, Inc., Pfizer, Inc., and Novartis AG.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453